Physician profile
Dylan G Racha
NPI 1790248524
$1,944.53
in general payments reported to CMS, 2019-2025
9 companies · $1,435 in 2025
The $1,435 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $67.22 · 2023: $242 · 2024: $200 · 2025: $1,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,054 · Travel and Lodging: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.64 |
| Travel and Lodging | $823.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $971.46 | 2025 | Trumatch |
| Zimvie INC. | $300.72 | 2023-2025 | |
| Stryker Corporation | $246.11 | 2022-2024 | Na, Smartlock, Vsp System, Vsp Cranial |
| Axogen | $132.74 | 2025 | |
| Kerecis Limited | $127.29 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Alafair Biosciences, INC. | $120.08 | 2025 | Versawrap |
| Biohorizons Implant Systems INC. | $17.67 | 2025 | Biohorizons Dental Implants |
| Janssen Pharmaceuticals, INC | $16.18 | 2024 | Xarelto |
| Align Technology, INC. | $12.28 | 2023 | Itero Element 5d Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Racha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.